Centering Those Engaged in Transactional Sex: A PrEP Innovation for Getting To Zero
C-PrEP+
2 other identifiers
interventional
24
1 country
1
Brief Summary
Using a participatory implementation science framework, I will test whether an adapted and community empowered group healthcare model, Centering PrEP+, is a feasible and acceptable health system intervention to improve the health of sex workers and their clients by increasing PrEP uptake and adherence. The conduct of this pilot study will provide an opportunity to gain experience with all aspects of intervention research, including recruitment, retention, implementing a randomization protocol, assessing measurement tools, delivering an intervention, and monitoring fidelity across two sites, tracking all metrics suggested by CONSORT, data collection and management of quantitative data from multiple sources (e.g., survey, laboratory), data analysis, and dissemination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for early_phase_1
Started Dec 2024
Shorter than P25 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2023
CompletedStudy Start
First participant enrolled
December 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 22, 2025
September 1, 2025
1.1 years
June 14, 2023
September 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Demographic Survey Questionnaire
8-Item Center for Disease Control (CDC) Behavioral Risk Factor Surveillance System determining gender identity, age, race/ethnicity, education level and income
Up to one year
PrEP Medication Adherence
Assessed from Dried Blood spot (DBS) detecting levels of tenofovir-containing PrEP reflecting use over the preceding 6-8 weeks
Through Study completion, an average of one year
HIV Related Knowledge Survey
18-Item brief HIV knowledge true/false questionnaire; cronbach alpha of 0.75-0.95
Through Study Completion, an average of one year
PrEP - related knowledge survey
6-item yes/no and 1 (3 point) Likert scale question
Through Study Completion, an average of one year
HIV Treatment Self-Efficacy survey
12 - Item HIV Treatment Self-Efficacy Scale (HIV-ASES) cronbach alpha of 0.7-0.92 (PrEP adapted)
Through Study Completion, an average of one year
Intention to Adhere to PrEP Survey
17-Item Intention to Adhere to HIV Treatment. Likert scale 1-6 cronbach alpha 0.81 (PrEP adapted)
Through Study Completion, an average of one year
Behaviors: HIV - Risk Assessment for Sexual Partnerships (H-RASP)
6 questions about condom use, STI testing, and PrEP adherence (yes/no, don't know), Cronbach alpha 0.85 20-item HIV self-management Scale (3-point Likert) Cronbach alpha 0.78 (PrEP adapted)
Through Study Completion, an average of one year
Patient Satisfaction Survey
8-Item Abbreviated Acceptability Rating Profile, 6-point Likert Scale from strongly disagree to strongly agree; cronbach alpha 0.97
Through Study Completion, an average of one year
Acceptability Survey
4-Item Acceptability of Intervention Measure (AIM) with a 5 option response scale (completely disagree, disagree scale, neither agree nor disagree, agree, completely agree), score range 4-16
Through Study Completion, an average of one year
Appropriateness Survey
4 item Intervention Appropriateness Measure (IAM; with a 5 option response scale (completely disagree, disagree scale, neither agree nor disagree, agree, completely agree), score range 4-16
Through Study Completion, an average of one year
Intervention Feasibility Survey
4-item Feasibility of Intervention Measure (FIM; with a 5 option response scale (completely disagree, disagree scale, neither agree nor disagree, agree, completely agree), score range 4-16
Through Study Completion, an average of one year
Secondary Outcomes (1)
Sustainability Survey
Through Study Completion, an average of one year
Study Arms (1)
C-PrEP+
EXPERIMENTALSex Workers engaged in group PrEP care.
Interventions
Rather than a one-on-one PrEP care visit, a cohort of 8-12 patients meet with the same providers at each visit for individual health assessments, linkages to services, and 75-90 minutes of group interactive learning and skill-building that centers patients' experiences. This approach to healthcare has great potential meet sex workers' HIV prevention needs, including optimal use of PrEP
Eligibility Criteria
You may qualify if:
- years of age or older;
- currently employed at Howard Brown Health
- are active in HIV prevention programs, epidemiology and/or GTZ 2030 projects;
- speak and understand English
You may not qualify if:
- \<18
- Not employed at Howard Brown Health
- Not active in HIV prevention programs, epidemiology and/or GTZ 2030 projects
- Does not speak and understand English
- Initiating PrEP at HBH
- ≥ 18 years of age;
- engaged in sex work, defined as the exchange of oral, vaginal, or anal sex for something of value, in the past 12 months;
- lives in Chicago area;
- speak/understand English.
- Not initiating PrEP at HBH
- \< 18 years of age;
- Identify as a victim of sex trafficking
- \) Not engaged in sex work, defined as the exchange of oral, vaginal, or anal sex for something of value, in the past 12 months; 4) Does NOT live in Chicago area; 5) Does NOT speak/understand English. 6) Does not/cannot provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Illinois at Chicago
Chicago, Illinois, 60612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Randi B Singer, PhD
University of Illinois at Chicago
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 14, 2023
First Posted
July 3, 2023
Study Start
December 12, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
September 22, 2025
Record last verified: 2025-09